April 29 (Reuters) - Three months ended March 31.
(Versus the same period a year earlier, in million rupees unless stated)
Net profit 806.2 vs 248.8
Net sales 6,568.4 vs 4,662.6
NOTE: Biocon (BION.BO) is India’s top listed biotechnology firm. The numbers are consolidated.
A Reuters poll of brokerages had estimated quarterly profit at 790.75 million rupees on net sales of 6,148 million rupees. (Reporting by Prashant Mehra in MUMBAI)